Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

17

Number of overlapping holdings

19.3%

% of WDNA's 91 holdings also in IDNA

37.8%

% of IDNA's 49 holdings also in WDNA

Overlap by Weight
Sector Drift (WDNA minus IDNA)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in WDNA
Weight
in IDNA
Overlap
TWIST BIOSCIENCE CORP. 4.3% 3.1% 3.1%
GERON CORP 2.5% 2.3% 2.3%
IOVANCE BIOTHERAPEUTICS INC 1.7% 2.1% 1.7%
SAREPTA THERAPEUTICS INC 1.7% 4.2% 1.7%
BLUEPRINT MEDICINES CORP. 2.6% 1.5% 1.5%

Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to IDNA
NOVOZYMES A/S-B SHARES 2.7%
AGIOS PHARMACEUTICALS INC 2.4%
FATE THERAPEUTICS INC 2.2%
NATERA INC 2.2%
VERICEL CORPORATION 2.1%
ELI LILLY & CO 2.1%
BRIDGEBIO PHARMA, INC. 1.6%
VERTEX PHARMACEUTICALS INC 1.6%
UNITED THERAPEUTICS CORP 1.5%
IONIS PHARMACEUTICALS, INC. 1.4%
WDNA Underweight Relative to IDNA
EXELIXIS INC -6.7%
GILEAD SCIENCES INC -4.9%
INCYTE CORP -4.9%
BEIGENE, LTD. -4.8%
REVOLUTION MEDICINES, INC. -4.7%
ROCHE HOLDING LTD -4.4%
BIONTECH SE SPONSORED ADR -4.2%
SANOFI-AVENTIS -4.0%
ARCELLX, INC. -3.9%
GSK PLC -3.4%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY